The Journal of Cell Biology · 2006 · 50 citations · 13 references
Life SciencesCell BiologyMolecular BiologyApoptosisNeurodegenerationSignal TransductionApoptosis In NeurodegenerationApoptosis RegulationNeurodegeneration MechanismsProtein DegradationSmall Gtpase SignalingNeurodegenerative Pathway MechanismsNuclear Body AssemblyNuclear Body DynamicsNuclear Body FunctionPolyglutamine DiseasesPolyglutamine Expansion DisordersPromyelocytic Leukemia Nuclear BodiesUbiquitin-proteasome Proteolysis
Polyglutamine diseases are inherited neurodegenerative diseases caused by the expanded polyglutamine proteins (polyQs). We have identified a novel guanosine triphosphatase (GTPase) named CRAG that contains a nuclear localization signal (NLS) sequence and forms nuclear inclusions in response to stress. After ultraviolet irradiation, CRAG interacted with and induced an enlarged ring-like structure of promyelocytic leukemia protein (PML) body in a GTPase-dependent manner. Reactive oxygen species (ROS) generated by polyQ accumulation triggered the association of CRAG with polyQ and the nuclear translocation of the CRAG-polyQ complex. Furthermore, CRAG promoted the degradation of polyQ at PML/CRAG bodies through the ubiquitin-proteasome pathway. CRAG knockdown by small interfering RNA in neuronal cells consistently blocked the nuclear translocation of polyQ and enhanced polyQ-mediated cell death. We propose that CRAG is a modulator of PML function and dynamics in ROS signaling and is protectively involved in the pathogenesis of polyglutamine diseases.
13
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Reiko Honda, Hirofumi Tanaka, Hideyo Yasuda · FEBS Letters · 1997 · 1.9K citations
Endothelin: A Novel Peptide in the Posterior Pituitary System
Toshihiro Yoshizawa, Osamu Shinmi, Adel Giaid et al. · Science · 1990 · 315 citations
Keqiang Ye, K. Joseph Hurt, Frederick Y. Wu et al. · Cell · 2000 · 148 citations · Full text